17-40628795-T-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_003079.5(SMARCE1):āc.1226A>Gā(p.Lys409Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000103 in 1,460,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003079.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCE1 | NM_003079.5 | c.1226A>G | p.Lys409Arg | missense_variant | Exon 11 of 11 | ENST00000348513.12 | NP_003070.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250780Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135536
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460388Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 726550
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial meningioma Uncertain:1
This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 409 of the SMARCE1 protein (p.Lys409Arg). This variant is present in population databases (rs770346178, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SMARCE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 818642). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at